NCT02040844View on ClinicalTrials.gov

Phase III Cat-PAD Follow-on Study

PHASE3CompletedINTERVENTIONAL
Enrollment

430

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Cat Allergy
Interventions
DRUG

Received Cat-PAD Treatment 1 in Study CP007 [NCT01620762]

DRUG

Received Cat-PAD Treatment 2 in Study CP007 [NCT01620762]

DRUG

Received Cat-PAD Treatment 3 in Study CP007 [NCT01620762]

All Listed Sponsors
lead

Circassia Limited

INDUSTRY

NCT02040844 - Phase III Cat-PAD Follow-on Study | Biotech Hunter | Biotech Hunter